Search

Your search keyword '"Antidepressive Agents analysis"' showing total 312 results

Search Constraints

Start Over You searched for: Descriptor "Antidepressive Agents analysis" Remove constraint Descriptor: "Antidepressive Agents analysis"
312 results on '"Antidepressive Agents analysis"'

Search Results

1. Development of Two Green and High-Throughput Microwell Spectrometric Platforms for Determination of Reboxetine, the First FDA-Approved Selective Noradrenaline Reuptake Inhibitor Antidepressant Drug.

2. Investigations into the Concentrations and Metabolite Profiles of Doping Agents and Antidepressants in Human Seminal Fluid Using Liquid Chromatography-Mass Spectrometry.

3. Field-deployable pencil lead-based electrochemical cell for the determination of the emerging contaminant and antidepressant drug venlafaxine in wastewater.

4. Enantioseparation strategies for sertraline by instrumental and crystallization-based techniques: An important issue in quality control.

5. Profiling the volatile compounds of Peganum harmala L. Based on multiple sample preparation coupled with gas chromatography-mass spectrometry analysis and explored its antidepressants-like activity.

6. Central composite design-assisted visual and non-invasive detection of sertraline by sweet lemon waste-derived core-shell AuNPs@CDs.

7. Fecal metabolomics combined with metagenomics sequencing to analyze the antidepressant mechanism of Yueju Wan.

8. Removal of two antidepressant active pharmaceutical ingredients from hospital wastewater by polystyrene-coated magnetite nanoparticles-assisted batch adsorption process.

9. Recent Advances in Analytical Techniques for Antidepressants Determination in Complex Biological Matrices: A Review.

10. Biological-Activity-Based Prioritization of Antidepressants in Wastewater in England and Japan.

11. Occurrence and removal of psychiatric pharmaceuticals in the Tehran South Municipal Wastewater Treatment Plant.

12. UPLC-MS/MS and Network Pharmacology-Based Analysis of Bioactive Anti-Depression Compounds in Betel Nut.

13. Identifying the effectual-combination ingredients of Zhi-zi-Hou-po decoction based on metabolic difference-oriented network regulation strategy.

15. Sensitive determination of Fluoxetine and Citalopram antidepressants in urine and wastewater samples by liquid chromatography coupled with photodiode array detector.

16. Xylogalacturonan-enriched pectin from the fruit pulp of Adansonia digitata: Structural characterization and antidepressant-like effect.

17. Evidence of repeated mirtazapine poisoning in children by hair analysis.

18. Molecular and behavioral responses of zebrafish embryos/larvae after sertraline exposure.

19. Preparation of bovine serum albumin restricted access octadecyl/phenyl-mixed-functionalized magnetic silica nanoparticles for magnetic solid phase extraction of antidepressants in aquatic products followed by UHPLC-MS/MS.

20. Study of the distribution of antidepressant drugs in vitreous humor using a validated GC/MS method.

21. Postmortem analysis of quetiapine and pregabalin in human bone.

22. LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium.

23. Developing and Validating a Fast and Accurate Method to Quantify 18 Antidepressants in Oral Fluid Samples Using SPE and LC-MS-MS.

24. Simultaneous quantification of nine components in the plasma of depressed rats after oral administration of Chaihu-Shugan-San by ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and its application to pharmacokinetic studies.

25. Validated LC-MS/MS Method for Simultaneous Quantitation of SAFit-1 and SAFit-2 in Mice Plasma: Application to a Pharmacokinetic Study.

26. Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant.

27. Combination of gel-electromembrane extraction with switchable hydrophilicity solvent-based homogeneous liquid-liquid microextraction followed by gas chromatography for the extraction and determination of antidepressants in human serum, breast milk and wastewater.

28. Hair analysis of antidepressants and antipsychotics-Overview of quantitative data.

29. Segmental analysis of antidepressant and antipsychotic drugs in the hair of schizophrenic patients.

30. Fast and efficient analyses of the post-mortem human blood and bone marrow using DI-SPME/LC-TOFMS method for forensic medicine purposes.

31. Textile-based non-invasive lithium drug monitoring: A proof-of-concept study for wearable sensing.

32. Anti-depressant activity of Erythrina variegata bark extract and regulation of monoamine oxidase activities in mice.

33. Magnetic solid-phase extraction coupled with UHPLC-MS/MS for four antidepressants and one metabolite in clinical plasma and urine samples.

34. Antibiotics and antidepressants occurrence in surface waters and sediments collected in the north of Portugal.

35. Hidden in the sand: Alteration of burying behaviour in shore crabs and cuttlefish by antidepressant exposure.

36. Postmortem analysis of human bone marrow aspirate - Quantitative determination of SSRI and SNRI drugs.

37. Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period.

38. Development and validation of an analytical procedure to detect spatio-temporal differences in antidepressant use through a wastewater-based approach.

39. Global scanning of selective serotonin reuptake inhibitors: occurrence, wastewater treatment and hazards in aquatic systems.

40. An Ultra-High Performance Liquid Chromatography-Electrospray Tandem Mass Spectrometric Method for Screening and Simultaneous Determination of Anorexic, Anxiolytic, Antidepressant, Diuretic, Laxative and Stimulant Drugs in Dietary Supplements Marketed for Weight Loss.

41. Development and validation of a method for analysing of duloxetine, venlafaxine and amitriptyline in human bone.

42. Antidepressants in breast milk; comparative analysis of excretion ratios.

43. Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

44. [Treatment-resistant depression and antidepressant plasma level: Proposal of a pharmacogenetic-integrative algorithm from a case report].

45. Comparison of Prioritisation Schemes for Human Pharmaceuticals in the Aquatic Environment.

46. Capillary electrophoresis for the analysis of antidepressant drugs: A review.

47. The antidepressant-like effect of probiotics and their faecal abundance may be modulated by the cohabiting gut microbiota in rats.

48. Capillary electrophoresis in the enantioseparation of modern antidepressants: An overview.

49. Multi-residue determination of psychoactive pharmaceuticals, illicit drugs and related metabolites in wastewater by ultra-high performance liquid chromatography-tandem mass spectrometry.

50. Comparative Study of Postmortem Concentrations of Antidepressants in Several Different Matrices.

Catalog

Books, media, physical & digital resources